Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).
Ocular Therapeutix has a consensus price target of $21.00.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $14.46 last updated December 16, 2025 at 4:36 PM EST.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix does not have any upcoming earnings scheduled.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.